Cannon 2016 Lung: Difference between revisions

From Bioblast
(Created page with "{{Publication |title=Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK (2016) Impaired lung mitochondrial respiration following perinatal nicotine exposure in rats. Lung 194:325...")
Β 
No edit summary
Β 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK (2016) Impaired lung mitochondrial respiration following perinatal nicotine exposure in rats. Lung 194:325-8. Β 
|title=Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK (2016) Impaired lung mitochondrial respiration following perinatal nicotine exposure in rats. Lung 194:325-8.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/26899624 PMID: 26899624]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/26899624 PMID: 26899624]
|authors=Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK
|authors=Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK
|year=2016
|year=2016
|journal=Lung
|journal=Lung
|abstract=Perinatal smoke/nicotine exposure predisposes to chronic lung disease and morbidity. Mitochondrial abnormalities may contribute as the PPARΞ³ pathway is involved in structural and functional airway deficits after perinatal nicotine exposure. We hypothesized perinatal nicotine exposure results in lung mitochondrial dysfunction that can be rescued by rosiglitazone (RGZ; PPARΞ³ receptor agonist). Sprague-Dawley dams received placebo (CON), nicotine (NIC, 1 mg kg(-1)), or NIC + RGZ (3 mg kg(-1)) daily from embryonic day 6 to postnatal day 21. Parenchymal lung (~10 mg) was taken from adult male offspring for mitochondrial assessment ''in situ''. ADP-stimulated O<sub>2<\sub> consumption was less in NIC and NIC + RGZ compared to CON (F[2,14] = 17.8; 4.5 Β± 0.8 and 4.1 Β± 1.4 vs. 8.8 Β± 2.5 pmol s mg(-1); ''p'' < 0.05). The respiratory control ratio for ADP, an index of mitochondrial coupling, was reduced in NIC and remediated in NIC + RGZ (F[2,14] = 3.8; ''p'' < 0.05). Reduced mitochondrial oxidative capacity and abnormal coupling were evident after perinatal nicotine exposure. RGZ improved mitochondrial function through tighter coupling of oxidative phosphorylation. Β 
|abstract=Perinatal smoke/nicotine exposure predisposes to chronic lung disease and morbidity. Mitochondrial abnormalities may contribute as the PPARΞ³ pathway is involved in structural and functional airway deficits after perinatal nicotine exposure. We hypothesized perinatal nicotine exposure results in lung mitochondrial dysfunction that can be rescued by rosiglitazone (RGZ; PPARΞ³ receptor agonist). Sprague-Dawley dams received placebo (CON), nicotine (NIC, 1 mg kg(-1)), or NIC + RGZ (3 mg kg(-1)) daily from embryonic day 6 to postnatal day 21. Parenchymal lung (~10 mg) was taken from adult male offspring for mitochondrial assessment ''in situ''. ADP-stimulated O<sub>2</sub> consumption was less in NIC and NIC + RGZ compared to CON (F[2,14] = 17.8; 4.5 Β± 0.8 and 4.1 Β± 1.4 vs. 8.8 Β± 2.5 pmol s mg(-1); ''p'' < 0.05). The respiratory control ratio for ADP, an index of mitochondrial coupling, was reduced in NIC and remediated in NIC + RGZ (F[2,14] = 3.8; ''p'' < 0.05). Reduced mitochondrial oxidative capacity and abnormal coupling were evident after perinatal nicotine exposure. RGZ improved mitochondrial function through tighter coupling of oxidative phosphorylation.
|mipnetlab=US CA San Diego Cannon DT, US CA Torrance Rossiter HB
}}
}}
{{Labeling
{{Labeling
Line 11: Line 12:
|organism=Rat
|organism=Rat
|tissues=Lung;gill
|tissues=Lung;gill
|couplingstates=OXPHOS
|preparations=Permeabilized tissue
|couplingstates=LEAK, OXPHOS, ET
|pathways=N, S, CIV, NS
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Labels, 2016-03
|additional=2016-03
}}
}}

Latest revision as of 12:00, 28 March 2018

Publications in the MiPMap
Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK (2016) Impaired lung mitochondrial respiration following perinatal nicotine exposure in rats. Lung 194:325-8.

Β» PMID: 26899624

Cannon DT, Liu J, Sakurai R, Rossiter HB, Rehan VK (2016) Lung

Abstract: Perinatal smoke/nicotine exposure predisposes to chronic lung disease and morbidity. Mitochondrial abnormalities may contribute as the PPARΞ³ pathway is involved in structural and functional airway deficits after perinatal nicotine exposure. We hypothesized perinatal nicotine exposure results in lung mitochondrial dysfunction that can be rescued by rosiglitazone (RGZ; PPARΞ³ receptor agonist). Sprague-Dawley dams received placebo (CON), nicotine (NIC, 1 mg kg(-1)), or NIC + RGZ (3 mg kg(-1)) daily from embryonic day 6 to postnatal day 21. Parenchymal lung (~10 mg) was taken from adult male offspring for mitochondrial assessment in situ. ADP-stimulated O2 consumption was less in NIC and NIC + RGZ compared to CON (F[2,14] = 17.8; 4.5 Β± 0.8 and 4.1 Β± 1.4 vs. 8.8 Β± 2.5 pmol s mg(-1); p < 0.05). The respiratory control ratio for ADP, an index of mitochondrial coupling, was reduced in NIC and remediated in NIC + RGZ (F[2,14] = 3.8; p < 0.05). Reduced mitochondrial oxidative capacity and abnormal coupling were evident after perinatal nicotine exposure. RGZ improved mitochondrial function through tighter coupling of oxidative phosphorylation.


β€’ O2k-Network Lab: US CA San Diego Cannon DT, US CA Torrance Rossiter HB


Labels: MiParea: Respiration, Exercise physiology;nutrition;life style, Pharmacology;toxicology 


Organism: Rat  Tissue;cell: Lung;gill  Preparation: Permeabilized tissue 


Coupling state: LEAK, OXPHOS, ET  Pathway: N, S, CIV, NS  HRR: Oxygraph-2k 

2016-03 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.